EYES
Second Sight Medical ProductsNASDAQHEALTHCAREHEALTH CARE EQUIPMENT & SUPPLIES
Key Statistics
Market Cap
$54.38M
P/E Ratio
—
EPS
$-0.23
Beta
2.56
52W High
$0.00
52W Low
$0.00
50-Day MA
$5.83
200-Day MA
$5.13
Dividend Yield
0.00%
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Second Sight Medical Products
Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics intended to provide machine vision to blind people. The company is headquartered in Sylmar, California.
Fundamentals
| Revenue (TTM) | 497,000 |
| Gross Profit (TTM) | 130,000 |
| EBITDA | $-9.08M |
| Operating Margin | 0.00% |
| Return on Equity | -13.40% |
| Return on Assets | -8.07% |
| Revenue/Share (TTM) | $0.03 |
| Book Value | $4.80 |
| Price-to-Book | 0.86 |
| Price-to-Sales (TTM) | 167.40 |
| EV/Revenue | 85.71 |
| EV/EBITDA | 0.20 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -71.90% |
| Shares Outstanding | $13.14M |
| Float | $9.38M |
| % Insiders | 28.61% |
| % Institutions | 5.72% |
More HEALTHCARE Stocks
Data last updated: 5/25/2026